
A top Democratic lawmaker on antitrust issues said Tuesday a bill aimed at reining in the market power of Big Tech platforms like Amazon.com and Alphabet’s Google had the votes to pass the both chambers of Congress in the next few weeks.
On the sidelines of an event to rally support for measures before the Senate and House of Representatives that would prevent tech platforms, including Apple and Facebook, from favoring their own businesses in search and other ways, Representative David Cicilline, chair of the House antitrust subcommittee, said: “I’m very confident when these bills come to the floor, they will pass. Convincingly.”
Asked when, he said: “Before we leave for the summer, my hope is that it will happen. Obviously, best case scenario would be in the next week. Worst case scenario in my view, the month of July.”
U.S. Senator Amy Klobuchar, chair of a Senate antitrust panel, also said last week that she enough support in the Senate to win passage.
Representative Ken Buck, a Republican sponsor, said Tuesday he supported the bill at least partially because of his view that conservative views are stifled online. “We’re being discriminated against,” he said.
The bills have been the subject of a ferocious amount of lobbying, with tech giants warning of dire consequences, like the disappearance of popular consumer online applications like Google Maps. Cicilline called some of those allegations “lies” on Tuesday.
The U.S. Chamber of Commerce opposes the bills, and said on Tuesday: “The legislation would empower government bureaucracy to reign over our economy. No longer would competition be evaluated on the merits, instead the interest of consumers would be sidelined in favor of the interest of competitors.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas